ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
2.040
+0.250 (13.97%)
At close: Jun 26, 2026, 4:00 PM EDT
2.002
-0.038 (-1.84%)
After-hours: Jun 26, 2026, 7:30 PM EDT
ALX Oncology Holdings Employees
ALX Oncology Holdings had 43 employees as of December 31, 2025. The number of employees decreased by 37 or -46.25% compared to the previous year.
Employees
43
Change (1Y)
-37
Growth (1Y)
-46.25%
Revenue / Employee
n/a
Profits / Employee
-$2,066,698
Market Cap
274.51M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Lyell Immunopharma | 161 |
| Entrada Therapeutics | 152 |
| Adagene | 128 |
| Invivyd | 122 |
| Niagen Bioscience | 117 |
| Zentalis Pharmaceuticals | 106 |
| SAB Biotherapeutics | 86 |
ALXO News
- 18 days ago - ALX Oncology Holdings Transcript: AGM 2026 - Transcripts
- 24 days ago - ALX Oncology Holdings Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 27 days ago - ALX Oncology to Present at the 2026 Jefferies Global Healthcare Conference in New York - GlobeNewsWire
- 7 weeks ago - ALX Oncology Holdings Earnings Call Transcript: Q1 2026 - Transcripts
- 7 weeks ago - ALX Oncology Holdings Earnings release: Q1 2026 - Filings
- 7 weeks ago - ALX Oncology Holdings Slides: Q1 2026 - Filings
- 7 weeks ago - ALX Oncology Holdings Quarterly report: Q1 2026 - Filings
- 7 weeks ago - ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update - GlobeNewsWire